Portopulmonary hypertension: Success with combined medical treatment

Portopulmonary hypertension is an uncommon disease associated with high morbidity and mortality, so its early diagnosis and treatment are essential. We report here the case of a 57‐year‐old man with portopulmonary hypertension caused by chronic hepatosplenic schistosomiasis and also liver cirrhosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, María, Esteban, Violeta, Ruiz, Paloma, Boira, Ignacio, Wickmann, Phillip, Sancho‐Chust, José N., Gil, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020675/
https://www.ncbi.nlm.nih.gov/pubmed/36935896
http://dx.doi.org/10.1002/rcr2.1114
Descripción
Sumario:Portopulmonary hypertension is an uncommon disease associated with high morbidity and mortality, so its early diagnosis and treatment are essential. We report here the case of a 57‐year‐old man with portopulmonary hypertension caused by chronic hepatosplenic schistosomiasis and also liver cirrhosis due to hepatitis C and alcoholism. As well as treating both diseases, portopulmonary hypertension was successfully managed with tadalafil and macitentan as maintenance therapy. This case reminds clinicians that pulmonary hypertension can be multifactorial, a good diagnosis and a multidisciplinary treatment can lead to improved prognosis.

Ejemplares similares